Sun Pharmaceutical Industries was sued for patent infringement on July 10 in Delaware District Court. The lawsuit, brought by Morris, Nichols, Arsht & Tunnell on behalf of Janssen Pharmaceuticals, ...

Janssen sued Teva in the US District Court for the District of New Jersey under the Hatch-Waxman Act after Teva filed an abbreviated new drug application (ANDA) on a generic version of Invega Sustenna ...

Cidara Therapeutics Inc (NASDAQ:CDTX) provided an update on the status of its ongoing CD388 program for the prevention of influenza A and B under an exclusive worldwide license and collaboration ...

On April 1, 2024 the Federal Circuit released its opinion in Janssen Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals USA, Inc. et al., affirming the district court’s finding that certain claims ...

CHARLESTON, W.Va. (WSAZ) - Monday, West Virginia’s Attorney General announced his office has reached a settlement with Janssen Pharmaceuticals that more than doubles the national settlement proposal ...

Baltimore settled with opioid manufacturer Johnson & Johnson and its subsidiary Janssen Pharmaceuticals on the eve of its trial against that company and two distributors of opioids that the city ...

Sanofi announced separate collaborations this week with two pharmaceutical companies based in New Jersey: Janssen Pharmaceuticals Inc., a Johnson & Johnson company, and Teva Pharmaceuticals. According ...

Decision follows promising interim efficacy and safety data from ongoing Phase 1 and 2a trials Cidara to receive a $7 million milestone payment and is eligible to receive an additional $685 million in ...

CHARLESTON, W.Va. (AP) - West Virginia will receive $99 million in a settlement finalized Monday with Johnson & Johnson's subsidiary Janssen Pharmaceuticals Inc. over the drugmaker's role in ...

Sun Pharmaceutical Industries was hit with a patent infringement lawsuit on July 9 in New Jersey District Court over its attempt to market generic versions of the antipsychotic drug Invega Sustenna.